Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seiren is a Japanese public materials and textile company with diversified operations spanning automotive, electronics, fashion, environmental/life materials, and medical materials. Within healthcare, the company develops and sells medical and nursing-care related materials and systems, including DEOEST medical deodorizer products for stoma care, NEW CureLa medical information systems, antiviral technology marketed as BYERUS, pure sericin-derived materials with applications including cosmetics and iPS cell storage, and artificial blood vessel base materials. The company is not a drug-development biotech or pharma company; rather, it is a commercial-stage industrial and medical materials supplier applying textile, composite, and chemical technologies to healthcare use cases. Seiren is listed in Japan and operates globally through the Seiren Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seiren.